Lindbrook Capital LLC Has $173,000 Stock Position in Kimberly-Clark Co. (NYSE:KMB)

Lindbrook Capital LLC lifted its stake in Kimberly-Clark Co. (NYSE:KMB) by 28.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,425 shares of the company’s stock after purchasing an additional 317 shares during the period. Lindbrook Capital LLC’s holdings in Kimberly-Clark were worth $173,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Cranbrook Wealth Management LLC grew its position in shares of Kimberly-Clark by 90.9% during the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock worth $26,000 after buying an additional 100 shares during the period. OFI Invest Asset Management acquired a new position in Kimberly-Clark during the third quarter valued at approximately $25,000. Centerpoint Advisors LLC increased its stake in Kimberly-Clark by 175.0% in the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock valued at $33,000 after purchasing an additional 175 shares in the last quarter. Wetzel Investment Advisors Inc. acquired a new stake in Kimberly-Clark in the fourth quarter worth $35,000. Finally, Bruce G. Allen Investments LLC bought a new position in shares of Kimberly-Clark during the fourth quarter worth $37,000. 76.29% of the stock is owned by institutional investors and hedge funds.

Kimberly-Clark Price Performance

Shares of NYSE KMB opened at $128.89 on Tuesday. The company has a debt-to-equity ratio of 6.94, a current ratio of 0.82 and a quick ratio of 0.54. The business has a 50-day moving average of $124.44 and a 200-day moving average of $122.43. The stock has a market capitalization of $43.42 billion, a price-to-earnings ratio of 24.79, a PEG ratio of 3.77 and a beta of 0.40. Kimberly-Clark Co. has a fifty-two week low of $116.32 and a fifty-two week high of $147.87.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings results on Wednesday, January 24th. The company reported $1.51 earnings per share for the quarter, missing analysts’ consensus estimates of $1.53 by ($0.02). The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.99 billion. Kimberly-Clark had a net margin of 8.63% and a return on equity of 260.47%. The firm’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.54 earnings per share. As a group, sell-side analysts predict that Kimberly-Clark Co. will post 6.84 earnings per share for the current fiscal year.

Kimberly-Clark Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 2nd. Shareholders of record on Friday, March 8th were paid a $1.22 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.88 dividend on an annualized basis and a yield of 3.79%. This is a boost from Kimberly-Clark’s previous quarterly dividend of $1.18. Kimberly-Clark’s dividend payout ratio (DPR) is currently 93.85%.

Wall Street Analysts Forecast Growth

KMB has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their price objective on shares of Kimberly-Clark from $125.00 to $131.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. JPMorgan Chase & Co. raised their price target on Kimberly-Clark from $119.00 to $125.00 and gave the stock an “underweight” rating in a research report on Thursday, January 18th. HSBC boosted their price objective on Kimberly-Clark from $134.00 to $146.00 and gave the company a “hold” rating in a research report on Thursday, March 28th. Evercore ISI upgraded shares of Kimberly-Clark from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $133.00 to $150.00 in a report on Thursday, March 28th. Finally, Barclays upped their price target on shares of Kimberly-Clark from $124.00 to $132.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Three analysts have rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $131.85.

Insider Activity

In other Kimberly-Clark news, Director Mark T. Smucker acquired 827 shares of the company’s stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the purchase, the director now directly owns 827 shares of the company’s stock, valued at $100,050.46. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Kimberly-Clark news, Director Mark T. Smucker bought 827 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The shares were acquired at an average cost of $120.98 per share, with a total value of $100,050.46. Following the acquisition, the director now owns 827 shares of the company’s stock, valued at $100,050.46. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Tristram Wilkinson sold 3,720 shares of the firm’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $121.00, for a total value of $450,120.00. Following the sale, the insider now directly owns 17,229 shares of the company’s stock, valued at approximately $2,084,709. The disclosure for this sale can be found here. Insiders own 0.62% of the company’s stock.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.